Epigenetic markers in rectal cancer.
Publication
, Journal Article
Xu, L; Czito, BG; Willett, CG
Published in: Clin Cancer Res
May 15, 2010
DNA methylation changes in rectal cancer may serve as a new screening marker and a tool for monitoring recurrence. Importantly, these changes may also function as a predictive marker to allow appropriate exclusion of (neo)adjuvant therapies in patients at low risk for disease recurrence, sparing them from potential treatment-related morbidities.
Duke Scholars
Published In
Clin Cancer Res
DOI
EISSN
1557-3265
Publication Date
May 15, 2010
Volume
16
Issue
10
Start / End Page
2699 / 2701
Location
United States
Related Subject Headings
- Rectal Neoplasms
- Oncology & Carcinogenesis
- Humans
- Epigenesis, Genetic
- DNA Methylation
- Biomarkers, Tumor
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Xu, L., Czito, B. G., & Willett, C. G. (2010). Epigenetic markers in rectal cancer. Clin Cancer Res, 16(10), 2699–2701. https://doi.org/10.1158/1078-0432.CCR-10-0559
Xu, Lei, Brian G. Czito, and Christopher G. Willett. “Epigenetic markers in rectal cancer.” Clin Cancer Res 16, no. 10 (May 15, 2010): 2699–2701. https://doi.org/10.1158/1078-0432.CCR-10-0559.
Xu L, Czito BG, Willett CG. Epigenetic markers in rectal cancer. Clin Cancer Res. 2010 May 15;16(10):2699–701.
Xu, Lei, et al. “Epigenetic markers in rectal cancer.” Clin Cancer Res, vol. 16, no. 10, May 2010, pp. 2699–701. Pubmed, doi:10.1158/1078-0432.CCR-10-0559.
Xu L, Czito BG, Willett CG. Epigenetic markers in rectal cancer. Clin Cancer Res. 2010 May 15;16(10):2699–2701.
Published In
Clin Cancer Res
DOI
EISSN
1557-3265
Publication Date
May 15, 2010
Volume
16
Issue
10
Start / End Page
2699 / 2701
Location
United States
Related Subject Headings
- Rectal Neoplasms
- Oncology & Carcinogenesis
- Humans
- Epigenesis, Genetic
- DNA Methylation
- Biomarkers, Tumor
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis